Skip to main content
. 2018 May 17;1(6):e40. doi: 10.1002/hsr2.40

Figure 3.

Figure 3

OS of high, medium, and low groups. OS rates were 79.6% in high VASH1 group, 51.2% in medium VASH1 group, and 47.6% in low VASH1 group. High VASH1 group had better prognosis than had low VASH1 level patients. P = .054, log‐rank test. OS indicates overall survival; VASH1, vasohibin‐1